Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

about

Identification of Optimal Insertion Site in Recombinant Newcastle Disease Virus (rNDV) Vector Expressing Foreign Gene to Enhance Its Anti-Tumor Effect

P2860

Q36162804-97A920C2-B43A-4132-9AC1-B0B87FAF1E22

P2860

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

Item

http://www.wikidata.org/entity/Q39131669

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

@en

Recombinant Newcastle disease virus Anhinga strain

@nl

type

Item

label

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

@en

Recombinant Newcastle disease virus Anhinga strain

@nl

prefLabel

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

@en

Recombinant Newcastle disease virus Anhinga strain

@nl

P1476

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy

@en

P2093

Deshan Li

http://www.w3.org/2001/XMLSchema#string

Guiping Ren

http://www.w3.org/2001/XMLSchema#string

Jiechao Yin

http://www.w3.org/2001/XMLSchema#string

Jingshu Geng

http://www.w3.org/2001/XMLSchema#string

Jinjiao He

http://www.w3.org/2001/XMLSchema#string

Lin Chen

http://www.w3.org/2001/XMLSchema#string

Shijun Yan

http://www.w3.org/2001/XMLSchema#string

Yunzhou Wu

http://www.w3.org/2001/XMLSchema#string

Zheng Lv

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

Estimating the world cancer burden: Globocan 2000.

Global cancer statistics in the year 2000.

Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines.

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus.

Antitumor efficacy of viral therapy using genetically engineered Newcastle disease virus [NDV(F3aa)-GFP] for peritoneally disseminated gastric cancer

Treatment modalities for hepatocellular carcinoma.

Oncolytic viruses in cancer therapy.

Newcastle disease virus V protein is a determinant of host range restriction.

P304

169-175

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7785/TCRT.2012.500356

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Qingzhong Yu

P577

2013-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23819497

http://www.w3.org/2001/XMLSchema#string

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

about

P2860

P2860

Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698